Loading stock data…
$0.63-0.07 (-10.47%)
Nexentis Technologies Inc., through its subsidiary, develops therapeutics related to cancer and inflammatory metabolic diseases.
Nexentis Technologies Inc. in the Basic Materials sector is trading at $0.63 with a market capitalization of $1M. The stock is currently near its 52-week low of $0.60, remaining 86.8% below its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the distress zone. Risk note: RSI 11 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 25/100 signals elevated caution as multiple indicators diverge.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $0 | $0↑ | -$68,000↓ | $2,000 | $0 |
| Gross Profit | — | — | — | $0↑ | -$2,000 |
| Operating Income | -$1.74M↑ | -$2.28M↓ | -$587,000↑ | -$1.33M↑ | -$2.63M |
| Net Income | -$11.14M↓ | -$6.58M↓ | $1.27M↑ | $429,000↑ | -$4.51M |
Nexentis Technologies Inc., through its subsidiary, develops therapeutics related to cancer and inflammatory metabolic diseases. It operates through two segments, Biotechnology Activity and Renewable Energy Projects. The company's pipeline includes M...